114 related articles for article (PubMed ID: 22235430)
21. Meningiomas and gliomas in juxtaposition: casual or causal coexistence? Report of two cases.
Matyja E; Kuchna I; Kroh H; Mazurowski W; Zabek M
Am J Surg Pathol; 1995 Jan; 19(1):37-41. PubMed ID: 7802136
[TBL] [Abstract][Full Text] [Related]
22. Classification of brain tumors by ex vivo 1H NMR spectroscopy.
Rutter A; Hugenholtz H; Saunders JK; Smith IC
J Neurochem; 1995 Apr; 64(4):1655-61. PubMed ID: 7891093
[TBL] [Abstract][Full Text] [Related]
23. [A plasminogen regulation system in brain tumors].
Kit OI; Frantsiyants EM; Kozlova LS; Rostorguev EE; Balyazin-Parfenov IV; Pogorelova YA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(2):22-27. PubMed ID: 28524122
[TBL] [Abstract][Full Text] [Related]
24. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Bresalier RS; Yan PS; Byrd JC; Lotan R; Raz A
Cancer; 1997 Aug; 80(4):776-87. PubMed ID: 9264362
[TBL] [Abstract][Full Text] [Related]
25. [Importance of immunohistochemistry for neuro-oncology. III. Demonstration of glial fibrillary acidic proteins (GFAP) in anaplastic astrocytomas and glioblastomas].
Martin H; Gottschalk J; Hufnagl P; Szymaś J
Zentralbl Allg Pathol; 1986; 132(3):209-14. PubMed ID: 3538706
[TBL] [Abstract][Full Text] [Related]
26. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein.
Herrmann M; Vos P; Wunderlich MT; de Bruijn CH; Lamers KJ
Stroke; 2000 Nov; 31(11):2670-7. PubMed ID: 11062293
[TBL] [Abstract][Full Text] [Related]
27. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
Gottschalk J; Szymaś J
Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
[TBL] [Abstract][Full Text] [Related]
28. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
Kunz J; Gottschalk J; Jänisch W; Schulz W
Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
Tichy J; Spechtmeyer S; Mittelbronn M; Hattingen E; Rieger J; Senft C; Foerch C
J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
[TBL] [Abstract][Full Text] [Related]
30. Desmoplastic astrocytoma of infancy--a case report.
Kandalkar B; Shah V; Shet T
Indian J Pathol Microbiol; 2001 Jul; 44(3):329-32. PubMed ID: 12024924
[TBL] [Abstract][Full Text] [Related]
31. The glucose transporter and blood-brain barrier of human brain tumors.
Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
33. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical characteristics of perivascular and intratumoral foam cells in neoplasms of neuroectodermal origin with lysozyme, alfa1-antitrypsin, protein S-100 and GFAP.
Kałuza J
Folia Histochem Cytobiol; 1990; 28(1-2):97-103. PubMed ID: 1965830
[TBL] [Abstract][Full Text] [Related]
35. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
36. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
37. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
38. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
39. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
40. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
